"COVID-19 associated divergent thrombotic thrombocytopenic purpura (TTP) syndromes reported so far, five and counting": Classification and possible therapeutic options.

Mir, Tajamul H

Mir, Tajamul H.

Mir TH; Department of Nephrology and Lupus/Vasculitis Centre, Khyber Medical Institute, Srinagar, India. Electronic address: thmir@rediffmail.com.

Thromb Res ; 219: 86-88, 2022 11.

Article in English | MEDLINE | ID: covidwho-2031709

Subject(s)

COVID-19; Purpura, Thrombotic Thrombocytopenic; ADAMTS13 Protein; COVID-19/complications; Humans; Purpura, Thrombotic Thrombocytopenic/complications; Purpura, Thrombotic Thrombocytopenic/therapy; Syndrome; Thiamine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Purpura, Thrombotic Thrombocytopenic / COVID-19 Topics: Long Covid Limits: Humans Language: English Journal: Thromb Res Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google